Frontlight ResearchEarly access
Trial site
Hematology Hospital, Chinese Academy of Medical Sciences
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia2 trials
- Acute myeloid leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- Gaucher disease1 trial
- Haemophilia1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 23 trials
- Phase 1/22 trials
- Phase 11 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Chengdu Zenitar Biomedical Technology Co., Ltd1 trial
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.1 trial
- Lingyi Biotech Co., Ltd.1 trial
- Otsuka Beijing Research Institute1 trial
- Pfizer1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gaucher disease1 recruiting
Closed trials
Completed
Completed
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026